Mereo BioPharma (MREO) Price to Book (2019 - 2026)

Mereo BioPharma (MREO) has reported Price to Book for 8 consecutive years, with 1.78 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 77.59% year-over-year to 1.78 in Q2 2026; TTM through Jun 2026 was 1.78, a 77.59% decrease from a year earlier, with the FY2025 full-year figure at 1.63, down 82.19% from the prior year.
• Price to Book was 1.78 for Q2 2026 at Mereo BioPharma, up from 1.55 in the prior quarter.
• Over five years, Price to Book peaked at 10.81 in Q1 2024 and troughed at 8.79 in Q3 2024.
• A 5-year average of 3.88 and a median of 3.36 in 2023 frame the typical range for Price to Book.
• The widest YoY moves for Price to Book: up 443.03% in 2024, down 365.82% in 2024.
• Over 5 years, Price to Book stood at 1.29 in 2022, then jumped by 396.3% to 6.41 in 2023, then soared by 42.37% to 9.13 in 2024, then tumbled by 82.19% to 1.63 in 2025, then gained by 9.72% to 1.78 in 2026.
• The last three Price to Book figures came in at 1.78 (Q2 2026), 1.55 (Q1 2026), and 1.63 (Q4 2025), per Business Quant data.